Contents:  Volume 42, Issue 10, November 19, 2003   [Index by Author]         Other Issues:          Viewpoint        Commentary        Clinical research: interventional cardiology        Editorial Comments        Clinical research: interventional cardiology        Clinical research: vascular effects of rofecoxib and rosiglitazone        Editorial Comments        Clinical research: vascular effects of rofecoxib and rosiglitazone        Editorial Comments        Clinical research: postoperative mortality after non-cardiac surgery        Clinical research: electrophysiologic disorders        Editorial Comments        Clinical study: electrophysiologic disorders        Clinical research: heart failure        Clinical research: effect of depression/anxiety on cardiac events        Editorial Comments        Clinical research: effect of depression/anxiety on cardiac events        Clinical research: cardiac imaging        Basic research        Editorial Comments        Basic research        Express Publication        ACC News        Letters to the Editor        Correction
Find articles in this issue containing these words: [Search ALL Issues]

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Viewpoint:

David S. Bach Choice of prosthetic heart valves:update for the next generation J Am Coll Cardiol 2003 42: 1717-1719. [Abstract] [Full Text] [Figures Only] [PDF]

Commentary:

Shahbudin H. Rahimtoola The next generation of prosthetic heart valves needs a proven track record of patient outcomes at 15 to 20 years J Am Coll Cardiol 2003 42: 1720-1721. [Abstract] [Full Text] [PDF]

Clinical research: interventional cardiology:

Mandeep Singh, Charanjit S. Rihal, Faith Selzer, Kevin E. Kip, Katherine Detre, and David R. Holmes Jr Validation of Mayo clinic risk adjustment model for in-hospital complications after percutaneous coronary interventions, using the National Heart, Lung, and Blood Institute dynamic registry J Am Coll Cardiol 2003 42: 1722-1728. [Abstract] [Full Text] [Figures Only] [PDF]

Editorial Comments:

P. J. de Feyter and E. McFadden Risk score for percutaneous coronary intervention: forewarned is forearmed J Am Coll Cardiol 2003 42: 1729-1730. [Full Text] [Figures Only] [PDF]

Clinical research: interventional cardiology:

Makoto Sahara, Hajime Kirigaya, Yuji Oikawa, Junji Yajima, Ken Ogasawara, Hiroshi Satoh, Kazuyuki Nagashima, Hitoshi Hara, Yusuke Nakatsu, and Tadanori Aizawa Arterial remodeling patterns before intervention predict diffuse in-stent restenosis: An intravascular ultrasound study J Am Coll Cardiol 2003 42: 1731-1738. [Abstract] [Full Text] [Figures Only] [PDF]

Rajendra H. Mehta, Kishore J. Harjai, David Cox, Gregg W. Stone, Bruce Brodie, Judy Boura, William O'Neill, Cindy L. Grines Primary Angioplasty in Myocardial Infarction (PAMI) Investigators Clinical and angiographic correlates and outcomes of suboptimal coronary flow inpatients with acute myocardial infarction undergoing primary percutaneous coronary intervention J Am Coll Cardiol 2003 42: 1739-1746. [Abstract] [Full Text] [Figures Only] [PDF]

Clinical research: vascular effects of rofecoxib and rosiglitazone:

Lawrence M. Title, Karen Giddens, Michele M. McInerney, Matthew J. McQueen, and Bassam A. Nassar Effect of cyclooxygenase-2 inhibition with rofecoxib on endothelial dysfunction and inflammatory markers in patients with coronary artery disease J Am Coll Cardiol 2003 42: 1747-1753. [Abstract] [Full Text] [PDF]

Editorial Comments:

Subodh Verma and Paul E. Szmitko Coxibs and the endothelium J Am Coll Cardiol 2003 42: 1754-1756. [Full Text] [PDF]

Clinical research: vascular effects of rofecoxib and rosiglitazone:

Jagdip S. Sidhu, Dahlia Cowan, and Juan-Carlos Kaski The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients J Am Coll Cardiol 2003 42: 1757-1763. [Abstract] [Full Text] [Figures Only] [PDF]

Editorial Comments:

Jorge Plutzky Peroxisome proliferator-activated receptors as therapeutic targets in inflammation J Am Coll Cardiol 2003 42: 1764-1766. [Full Text] [PDF]

Clinical research: postoperative mortality after non-cardiac surgery:

Miodrag Filipovic, Raban Jeger, Cecilia Probst, Thierry Girard, Matthias Pfisterer, Lorenz Gürke, Karl Skarvan, and Manfred D. Seeberger Heart rate variability and cardiac troponin I are incremental and independent predictors of one-year all-cause mortality after major noncardiac surgery in patients at risk of coronary artery disease J Am Coll Cardiol 2003 42: 1767-1776. [Abstract] [Full Text] [Figures Only] [PDF]

Clinical research: electrophysiologic disorders:

Susan P. Etheridge, Steven J. Compton, Martin Tristani-Firouzi, and Jay W. Mason A new oral therapy for long QT syndrome: Long-term oral potassium improves repolarization in patients with HERG mutations J Am Coll Cardiol 2003 42: 1777-1782. [Abstract] [Full Text] [Figures Only] [PDF]

Editorial Comments:

Elizabeth Bisinov, James H. Mitchell, and Craig T. January Potassium andlong QT syndrome: A new look at an old therapy J Am Coll Cardiol 2003 42: 1783-1784. [Full Text] [PDF]

Clinical study: electrophysiologic disorders:

Andreas Boldt, Ulrike Wetzel, Josef Weigl, Jens Garbade, Jörg Lauschke, Gerhard Hindricks, Hans Kottkamp, Jan Fritz Gummert, and Stefan Dhein Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease J Am Coll Cardiol 2003 42: 1785-1792. [Abstract] [Full Text] [Figures Only] [PDF]

Clinical research: heart failure:

Susan P. Wright, Robert N. Doughty, Ann Pearl, Greg D. Gamble, Gillian A. Whalley, Helen J. Walsh, Gary Gordon, Warwick Bagg, Helen Oxenham, Tim Yandle, Mark Richards, and Norman Sharpe Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: A randomized, controlled trial J Am Coll Cardiol 2003 42: 1793-1800. [Abstract] [Full Text] [Figures Only] [PDF]

Clinical research: effect of depression/anxiety on cardiac events:

Jacqueline J. M. H. Strik, Johan Denollet, Richel Lousberg, and Adriaan Honig Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption after myocardial infarction J Am Coll Cardiol 2003 42: 1801-1807. [Abstract] [Full Text] [Figures Only] [PDF]

Editorial Comments:

Deirdre Lane, Douglas Carroll, and Gregory Y. H. Lip Anxiety, depression, and prognosis after myocardial infarction: Is there a causal association? J Am Coll Cardiol 2003 42: 1808-1810. [Full Text] [PDF]

Clinical research: effect of depression/anxiety on cardiac events:

John S. Rumsfeld, Edward Havranek, Frederick A. Masoudi, Eric D. Peterson, Philip Jones, Joseph F. Tooley, Harlan M. Krumholz, John A. Spertus Cardiovascular Outcomes Research Consortium (CORC) Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure J Am Coll Cardiol 2003 42: 1811-1817. [Abstract] [Full Text] [Figures Only] [PDF]

Clinical research: cardiac imaging:

Aiden Abidov, Jeroen J. Bax, Sean W. Hayes, Rory Hachamovitch, Ishac Cohen, James Gerlach, Xingping Kang, John D. Friedman, Guido Germano, and Daniel S. Berman Transient ischemic dilation ratio of the left ventricle is a significant predictor of future cardiac events in patients with otherwise normal myocardial perfusion SPECT J Am Coll Cardiol 2003 42: 1818-1825. [Abstract] [Full Text] [Figures Only] [PDF]

Basic research:

Ulrich Hink, Matthias Oelze, Philip Kolb, Markus Bachschmid, Ming-Hui Zou, Andreas Daiber, Hanke Mollnau, Michael August, Stefan Baldus, Nikos Tsilimingas, Ulrich Walter, Volker Ullrich, and Thomas Münzel Role for peroxynitrite in the inhibition of prostacyclin synthase in nitrate tolerance J Am Coll Cardiol 2003 42: 1826-1834. [Abstract] [Full Text] [Figures Only] [PDF]

Editorial Comments:

John D. Parker Therapy with nitrates: increasing evidence of vascular toxicity J Am Coll Cardiol 2003 42: 1835-1837. [Full Text] [PDF]

Basic research:

Luciano Cominacini, Anna Fratta Pasini, Ulisse Garbin, Cristina Nava, Anna Davoli, Marco Criscuoli, Attilio Crea, Tatsuya Sawamura, and Vincenzo Lo Cascio Nebivolol and its 4-keto derivative increase nitric oxide in endothelial cells by reducing its oxidative inactivation J Am Coll Cardiol 2003 42: 1838-1844. [Abstract] [Full Text] [Figures Only] [PDF]

Tzu-Hurng Cheng, Pao-Yun Cheng, Neng-Lang Shih, Iuan-Bor Chen, Danny Ling Wang, and Jin-Jer Chen Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts J Am Coll Cardiol 2003 42: 1845-1854. [Abstract] [Full Text] [Figures Only] [PDF]

Express Publication:

Robert A. Kloner, Adolph M. Hutter, Jeffrey T. Emmick, Malcolm I. Mitchell, Jonathan Denne, and Graham Jackson Time course of the interaction between tadalafil and nitrates J Am Coll Cardiol 2003 42: 1855-1860. [Abstract] [Full Text] [Figures Only] [PDF]

ACC News:

Newly elected members of the college J Am Coll Cardiol 2003 42: 1861-1863. [PDF]

Letters to the Editor:

Maria Martin Fernandez, J. J. Rodriguez Reguero, and Pelayo González Angiotensin-converting enzyme polymorphism (I/D) and coronary heart disease in young adults J Am Coll Cardiol 2003 42: 1864. [Full Text] [PDF]

Vicky A. Cameron and Barry R. Palmer Angiotensin-converting enzyme polymorphism (I/D) and coronary heart disease in young adults: Reply J Am Coll Cardiol 2003 42: 1864. [Full Text] [PDF]

Correction:

Correction J Am Coll Cardiol 2003 42: 1865. [Full Text] [PDF]

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.